CO5660272A2 - Vacunas bovinas con adyuvantes - Google Patents

Vacunas bovinas con adyuvantes

Info

Publication number
CO5660272A2
CO5660272A2 CO05090260A CO05090260A CO5660272A2 CO 5660272 A2 CO5660272 A2 CO 5660272A2 CO 05090260 A CO05090260 A CO 05090260A CO 05090260 A CO05090260 A CO 05090260A CO 5660272 A2 CO5660272 A2 CO 5660272A2
Authority
CO
Colombia
Prior art keywords
assistants
subunit
bovine vaccines
vaccines
bovine
Prior art date
Application number
CO05090260A
Other languages
English (en)
Inventor
Hsien-Jue Chu
Wumin Li
Original Assignee
Wyeth Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wyeth Corp filed Critical Wyeth Corp
Publication of CO5660272A2 publication Critical patent/CO5660272A2/es

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/02Bacterial antigens
    • A61K39/025Enterobacteriales, e.g. Enterobacter
    • A61K39/0258Escherichia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/55Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552Veterinary vaccine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55505Inorganic adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55566Emulsions, e.g. Freund's adjuvant, MF59
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Abstract

1.- Una composición de vacuna caracterizada porque comprende: un componente inmunogénicamente activo seleccionado del grupo que consiste de subunidad de E. coli 0157-H7 inactivada o muerta o una subunidad o mezclas de los mismos, un adyuvante de aceite metabolizable; y opcionalmente un portador aceptable farmacéuticamente.
CO05090260A 2003-03-12 2005-09-07 Vacunas bovinas con adyuvantes CO5660272A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45418203P 2003-03-12 2003-03-12

Publications (1)

Publication Number Publication Date
CO5660272A2 true CO5660272A2 (es) 2006-07-31

Family

ID=32990880

Family Applications (1)

Application Number Title Priority Date Filing Date
CO05090260A CO5660272A2 (es) 2003-03-12 2005-09-07 Vacunas bovinas con adyuvantes

Country Status (12)

Country Link
US (1) US20040180060A1 (es)
EP (1) EP1601375A2 (es)
JP (1) JP2006519880A (es)
AR (1) AR043539A1 (es)
AU (2) AU2004220543A1 (es)
BR (1) BRPI0408249A (es)
CA (1) CA2517498A1 (es)
CO (1) CO5660272A2 (es)
MX (1) MXPA05009447A (es)
NZ (1) NZ542253A (es)
TW (1) TWI350174B (es)
WO (1) WO2004080400A2 (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2465331C2 (ru) * 2003-10-31 2012-10-27 Дзе Юниверсити Оф Бритиш Коламбиа Бактериальные факторы вирулентности и варианты их применения
MX2010005014A (es) * 2007-11-06 2010-06-30 Wyeth Llc Vacuna viva avirulenta de mycoplasma hyopneumoniae con adyuvante.
WO2011043962A2 (en) * 2009-10-07 2011-04-14 Wyeth Llc Compositions comprising adjuvant, macrolide and proteinaceous antigen and methods of use thereof
EP2711013A4 (en) * 2011-05-18 2015-03-04 Ajinomoto Kk IMMUNSTIMULANDS FOR ANIMALS, FEED THEREFOR AND MANUFACTURING PROCESS THEREFOR
WO2015042423A2 (en) * 2013-09-19 2015-03-26 Zoetis Llc Vaccine

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0827028A (ja) * 1994-07-21 1996-01-30 Nippon Seibutsu Kagaku Kenkyusho 油性アジュバント及びアルミニウムゲルアジュバントからなる動物用ワクチン製剤
US5730989A (en) * 1995-02-16 1998-03-24 Novavax, Inc. Oral vaccine against gram negative bacterial infection
US5976580A (en) * 1995-06-07 1999-11-02 Novus International, Inc. Nutrient formulation and process for enhancing the health, livability, cumulative weight gain or feed efficiency in poultry and other animals
US5965128A (en) * 1997-08-13 1999-10-12 University Of Georgia Research Foundation Inc. Control of enterohemorrhagic E. coli 0157:H7 in cattle by probiotic bacteria and specific strains of E. coli
JP4282804B2 (ja) * 1998-12-24 2009-06-24 新日本石油株式会社 アジュバント組成物
EP1195162B1 (en) * 1999-03-03 2008-06-04 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
GB9923176D0 (en) * 1999-09-30 1999-12-01 Smithkline Beecham Biolog Novel composition
JP2001131087A (ja) * 1999-11-05 2001-05-15 Chemo Sero Therapeut Res Inst オイルアジュバントワクチン
ES2256062T3 (es) * 1999-11-29 2006-07-16 Intervet International Bv Proteina lppq antigenica de mycoplasma mycoides subsp.mycoides sc, su preparacion y uso.
US6162441A (en) * 1999-12-15 2000-12-19 Republic Of Korea (Management: Rural Development Administration) Method for the production of anti-escherichia. coli O157 : H7 antibody
AUPQ761200A0 (en) * 2000-05-19 2000-06-15 Hunter Immunology Limited Compositions and methods for treatment of mucosal infections
US7560484B2 (en) * 2000-08-31 2009-07-14 The Kitasato Institute Vaccine preparation containing fatty acid as a constituent
US7300659B2 (en) * 2001-01-04 2007-11-27 University Of Saskatchewan Enterohemorrhagic Escherichia coli vaccine
WO2002064162A2 (en) * 2001-02-13 2002-08-22 Government Of The United States, As Represented By The Secretary Of The Army Vaccine for transcutaneous immunization
EP1314359A1 (en) * 2001-11-21 2003-05-28 N.V. Seghers Nutrition Sciences Growth promoter composition for animals

Also Published As

Publication number Publication date
US20040180060A1 (en) 2004-09-16
AU2004220543A1 (en) 2004-09-23
TW200423956A (en) 2004-11-16
CA2517498A1 (en) 2004-09-23
BRPI0408249A (pt) 2006-03-01
WO2004080400A3 (en) 2005-03-03
JP2006519880A (ja) 2006-08-31
EP1601375A2 (en) 2005-12-07
WO2004080400A2 (en) 2004-09-23
MXPA05009447A (es) 2005-11-23
AR043539A1 (es) 2005-08-03
AU2010202344A1 (en) 2010-07-01
TWI350174B (en) 2011-10-11
NZ542253A (en) 2008-07-31

Similar Documents

Publication Publication Date Title
AR064009A1 (es) Metodo de inmunizacion contra los 4 serotipos del dengue
AR047728A1 (es) Adyuvante antimicrobiano y uso de agentes antimicrobianos como adyuvante de vacunas
UY26555A1 (es) Composición farmacéutica para modulación inmunológica y preparación de vacunas
AR057586A1 (es) Vacuna combinada que comprende un virus atenuado de la diarrea viral bovina
ECSP066662A (es) Preparación farmacéutica que comprende un anticuerpo contra el receptor egf
ECSP056229A (es) Una composición farmacéutica que comprende formas polimórficas de 3-(4-amino-1-oxo-1.3 dyhidro-isoindol-2-il)-piperidina-2,6-diona para el tratamiento y manejo de cánceres
EA200700904A1 (ru) Вакцины против вируса японского энцефалита и вируса западного нила
AR041880A1 (es) Composicion inmunogena
CY1106669T1 (el) Βελτιωμενο i mycoplasma hy opneumoniae/ i εμβολιο βακτηρινης
ECSP066448A (es) Péptidos macrocíclicos activos contra el virus de la hepatits c
ES2244617T3 (es) Vacunas a base de salmonelas en las cuales los genes ssa han sido inactivados.
PT1187629E (pt) Composicao adjuvante que compreende saponina e um oligonucleotido imunoestimulador
AR036643A1 (es) Compuestos organicos
CO5540349A2 (es) Preparacion vacunal de virus de influenza inactivado
RS53184B (en) COMPOSITION OF VACCINES FOR ADMINISTRATION FOR PREVENTING OR DETERMINING WEST NIL ENCEPHALITIS IN EQUID
ATE501726T1 (de) Zusammensetzung mit immunogenen mikroteilchen
ATE270707T1 (de) Entepneumovirus und entsprechendes impfstoff
AR059203A1 (es) Composiciones para uso vaginal
CO5660272A2 (es) Vacunas bovinas con adyuvantes
DK1259259T3 (da) Mucosal adjuvansformulering
AR053571A1 (es) Prevencion de infeccion por vih
CO6290701A2 (es) Vacuna de vih que comprende una proteina de fusion y un agente estabilizador
AR034200A1 (es) Agente para el cuidado de lentes de contacto, su uso, y procedimiento de limpieza
IT1318524B1 (it) Composizioni a rilascio controllato contenenti un principio attivo,preferibilmente melatonina, e processo di preparazione delle stesse.
NO20040611L (no) Ekspanderbar gastrisk retensjonsanordning.

Legal Events

Date Code Title Description
FC Application refused